HP-β-CD NEW
| Price | $33 |
| Package | 500mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: HP-β-CD | CAS No.: 128446-35-5 |
| Purity: ≥98% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | HP-β-CD |
| Description | HP-β-CD (HP-β-CD) is a widely used drug delivery vehicle to improve stability and bioavailability. |
| In vitro | Cell treatment with (2-hydroxypropyl)-β-cyclodextrin can activate the activation of the transcription factor EB (the main regulator of lysosomal function and autophagy) and enhance the cell's autophagy clearance ability[1]. HP-β-CD treatment reduces intracellular cholesterol resulting in significant leukemic cell growth inhibition through G2/M cell-cycle arrest and apoptosis. The IC50 values for HP-β-CD after 72 hours exposure are in the range of 3.86–10.09 mM. HP-β-CD also shows anticancer effects against CML cells expressing a T315I BCR-ABL mutation (that confers resistance to most ABL tyrosine kinase inhibitors), and hypoxia-adapted CML cells that have characteristics of leukemic stem cells. In addition, colony forming ability of human primary AML and CML cells is inhibited by HP-β-CD[2]. |
| In vivo | Intraperitoneal injection of HP-β-CD significantly improves survival in leukemia mouse models. Systemic administration of HP-β-CD to mice has no significant adverse effects[2]. |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 45 mg/mL (29.19 mM) H2O : 50 mg/mL, Sonication is recommended. |
| Keywords | (2Hydroxypropyl)βcyclodextrin | HP-b-CD | HP-beta-CD | (2 Hydroxypropyl) β cyclodextrin | Inhibitor | Hydroxypropyl-beta-cyclodextrin | inhibit | Hydroxypropyl-b-cyclodextrin |
| Related Compound Libraries | Macrocyclic Compound Library | Bioactive Compound Library | Anti-Diabetic Compound Library | Inactive Ingredient Library | Bioactive Compounds Library Max | Preclinical Compound Library | Anti-Metabolism Disease Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $10.00/25kg |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-10-30 | |
| $0.00/1KG |
VIP1Y
|
Wuhan Fortuna Chemical Co.,Ltd
|
2024-08-10 | |
| $6.00/1kg |
VIP1Y
|
HebeiShuoshengImportandExportco.,Ltd
|
2024-08-09 | |
| $8.80/1kg |
VIP1Y
|
Shandong Deshang Chemical Co., Ltd.
|
2024-08-05 | |
| $120.00/1kg |
VIP1Y
|
Watson Biotechnology Co.,Ltd
|
2024-07-18 | |
| $6.00/1kg |
VIP1Y
|
Hebei Longbang Technology Co., Ltd
|
2024-05-14 | |
| $120.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-05-08 | |
| $15.00/1kg |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-28 | ||
| $4.00/1KG |
VIP1Y
|
Hebei Saisier Technology Co., LTD
|
2024-04-15 | |
| $31.00/1kg |
Wuhan Han Sheng New Material Technology Co.，Ltd
|
2024-01-31 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY